Clinical trial for Opioid Use Disorder
Official title Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
ClinicalTrials.gov ID: NCT06768814
What this study is testing
- What it's testing
- The study compares outcomes for patients who go to the center with those who do not, to see if the center improves recovery and care access.
- Who it's for
- People who have overdosed or are at risk of overdosing and have contacted Seattle Fire Department emergency medical services.
- What's involved
- Participants are taken to the center, stay less than 24 hours, and receive monitoring, medication for withdrawal, and help connecting to ongoing treatment and harm‑reduction supplies.
- Time commitment
- The stay is under 24 hours; no additional visits are required by the study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Verbally consents to transfer of care to SASC.
- Awake and oriented to person and place, with no significant deficits in mental status or neurological function.
- Age \>=18
- Patent airway and effective respirations with adequate oxygenation.
- Stable heart rate and blood pressure, with no evidence of cardiac arrhythmias or other significant cardiovascular disfunction.
You likely can't join if
- \- People under 18 and who do not meet SASC admission criteria will be excluded.
See the full eligibility criteria
- Verbally consents to transfer of care to SASC.
- Awake and oriented to person and place, with no significant deficits in mental status or neurological function.
- Age \>=18
- Patent airway and effective respirations with adequate oxygenation.
- Stable heart rate and blood pressure, with no evidence of cardiac arrhythmias or other significant cardiovascular disfunction.
- Heart rate: 45-130
- Blood pressure: systolic 95-190, diastolic 50-120
- Respiratory rate: 10-24
- SpO2: \>92 on room air or supplemental O2 via nasal cannula.
- SpO2 \<92% with supplemental O2 requires ED transfer.
- EtCO2: \<50
- Temperature: 95.5-100.3 F
- Blood glucose (if indicated): 60-300
- Dizziness or loss of balance
- Blurred vision or double vision
- Sensitivity to light or noise
- Seizures or convulsions
- Weakness or numbness in the arms or legs
- Persistent or worsening headache
- CSF or blood leaking from the nose or ears
- Unequal pupils or pupils that are slow to react to light.
- No signs of other traumatic injury or medical needs requiring immediate treatment.
- No signs of respiratory infection. Screen for COVID-19. See COVID-19 Screening protocol.
- \- People under 18 and who do not meet SASC admission criteria will be excluded.
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.